Dr Dana Rizk is Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham (UAB) and a VOYXACT VISIONARY Study Investigator and Co-Chair of the Steering Committee.

The coprimary endpoints were the proportion of zasocitinib-treated patients achieving static Physician Global Assessment (sPGA) of clear (0) or almost clear (1) and Psoriasis Area and Severity Index ...

The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...

TRITON3 trial data support FDA traditional approval of rucaparib for treating adults with BRCA-mutated metastatic castration-resistant prostate cancer.

According to Lilly, a New Drug Application for orforglipron for the treatment of adults with obesity or overweight has been submitted to the Food and Drug Administration.

No reduction seen in in-hospital death by day 28 with use of ketamine rather than etomidate to induce anesthesia in critically ill adults undergoing tracheal intubation ...

The proposed regulatory action would bar hospitals from providing pediatric patients (those under the age of 18 years) from receiving gender-affirming procedures, including pharmaceutical and surgical ...

The FDA said retailers were first notified of the recall November 8, after health officials determined the formula was the likely source of the outbreak. The company expanded the recall to all ByHeart ...

HealthDay News — Flu season is getting an early start in New York City, with doctors reporting a sharp jump in cases weeks sooner than normal.

Fasedienol is a first-in-class pherine nasal spray that is designed to modulate the olfactory-limbic amygdala fear and anxiety neurocircuits.

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...